Alberta Investment Management Corp Takes $4.68 Million Position in Waters Corporation $WAT

Alberta Investment Management Corp purchased a new position in Waters Corporation (NYSE:WAT) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 15,600 shares of the medical instruments supplier’s stock, valued at approximately $4,677,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Syon Capital LLC raised its position in Waters by 35.2% in the third quarter. Syon Capital LLC now owns 1,033 shares of the medical instruments supplier’s stock worth $310,000 after purchasing an additional 269 shares in the last quarter. NEOS Investment Management LLC lifted its position in Waters by 35.3% during the 3rd quarter. NEOS Investment Management LLC now owns 5,200 shares of the medical instruments supplier’s stock worth $1,559,000 after buying an additional 1,356 shares in the last quarter. Mondrian Investment Partners LTD bought a new stake in shares of Waters during the third quarter valued at approximately $1,397,000. Vanguard Group Inc. raised its position in Waters by 3.3% in the 3rd quarter. Vanguard Group Inc. now owns 7,656,891 shares of the medical instruments supplier’s stock worth $2,295,612,000 after purchasing an additional 246,128 shares during the last quarter. Finally, Northwestern Mutual Investment Management Company LLC raised its position in shares of Waters by 39.4% during the third quarter. Northwestern Mutual Investment Management Company LLC now owns 8,101 shares of the medical instruments supplier’s stock worth $2,429,000 after acquiring an additional 2,291 shares during the last quarter. 94.01% of the stock is currently owned by institutional investors.

Waters Stock Performance

Shares of Waters stock opened at $328.68 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.41 and a quick ratio of 1.01. The firm has a market cap of $19.57 billion, a price-to-earnings ratio of 30.52, a price-to-earnings-growth ratio of 2.26 and a beta of 1.18. The stock’s 50-day moving average is $375.40 and its 200-day moving average is $348.35. Waters Corporation has a one year low of $275.05 and a one year high of $414.15.

Waters (NYSE:WAT) last announced its earnings results on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.50 by $0.03. Waters had a return on equity of 34.79% and a net margin of 20.30%.The business had revenue of $932.36 million for the quarter, compared to analyst estimates of $928.17 million. During the same quarter last year, the firm earned $4.10 EPS. Waters’s revenue for the quarter was up 6.9% compared to the same quarter last year. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. Equities analysts predict that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on WAT. UBS Group cut their target price on shares of Waters from $395.00 to $370.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 10th. Wolfe Research upgraded shares of Waters from a “peer perform” rating to an “outperform” rating and set a $480.00 target price for the company in a research report on Wednesday, December 10th. Evercore started coverage on Waters in a research report on Tuesday, February 10th. They issued a “hold” rating and a $360.00 price target on the stock. TD Cowen reissued a “hold” rating on shares of Waters in a research note on Wednesday, November 5th. Finally, Wells Fargo & Company reduced their target price on Waters from $415.00 to $355.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 11th. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $397.68.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.